PDS Biotechnology Corp — Director's Dealing 2025

Jul 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2025-06-12

Reporting Person: Shepard Kirk V. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-12	Employee Stock Option (Right to Buy)	$1.79	A	150000	Acquired	2035-06-12	Common Stock (150000)	Direct

Footnotes

F1: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.